SAHARA: Long-term Assesment of Patients Operated for Hypospadias in Their Childhood : Urinary, Aesthetical, Sexual and Psycho-social Consequences

Sponsor
Centre Hospitalier Universitaire de Besancon (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05319782
Collaborator
(none)
66
1
12

Study Details

Study Description

Brief Summary

The purpose of this study is to assess the long term urinary, sexual, cosmetic and psycho-social outcomes of adult patients operated for hypospadias during childhood

Condition or Disease Intervention/Treatment Phase
  • Other: Urethral stenosis assesment
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
66 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
Long-term Assesment of Patients Operated for Hypospadias in Their Childhood : Urinary, Aesthetical, Sexual and Psycho-social Consequences
Anticipated Study Start Date :
Apr 1, 2022
Anticipated Primary Completion Date :
Apr 1, 2023
Anticipated Study Completion Date :
Apr 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Experimental arm

Other: Urethral stenosis assesment
Auto-questionnaires + Clinical examination + Flow metry and post-mictional residue

Outcome Measures

Primary Outcome Measures

  1. Proportion of adult patients with urethral stenosis following a repair surgery performed during childhood [Day 1]

    Proportion of adult patients with urethral stenosis following a repair surgery performed during childhood, assessed with flowmetry (maximal urinary flow)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 23 Years
Sexes Eligible for Study:
Male
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients operated for hypospadias during childhood (before the age of 15) at the University Hospital of Besançon (France)
Exclusion Criteria:
  • Patients with a non-operated hypospadias

  • Opposition to participate

  • Legal incapacity

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Centre Hospitalier Universitaire de Besancon

Investigators

  • Principal Investigator: Yann CHAUSSY, MD, PhD, CHU De Besançon

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Centre Hospitalier Universitaire de Besancon
ClinicalTrials.gov Identifier:
NCT05319782
Other Study ID Numbers:
  • 2021/663
First Posted:
Apr 8, 2022
Last Update Posted:
Apr 8, 2022
Last Verified:
Apr 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 8, 2022